XML 35 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Assumptions Used in Determining Fair Value of Option Awards

The following table provides the assumptions used in determining the fair value of option awards for the three and nine months ended September 30, 2024 and 2023:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2024

 

2023

 

2024

 

2023

Expected volatility

 

77.34% - 77.74%

 

81.8% - 82.1%

 

77.34% - 84.50%

 

81.4% - 83.7%

Risk-free interest rate

 

3.46% - 4.15%

 

4.33% - 4.35%

 

3.46% - 4.62%

 

3.58% - 4.35%

Expected dividend yield

 

0%

 

0%

 

0%

 

0%

Expected term (in years)

 

6.1

 

5.3 - 6.11

 

6.05 - 6.1

 

4.95 - 6.11

Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended September 30, 2024 (in thousands, except share and per share amounts):

 

 

 

Number of
Outstanding Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

(Years)

 

 

 

 

Balance at December 31, 2023

 

 

5,532,871

 

 

$

4.12

 

 

 

8.55

 

 

$

40,290

 

Granted

 

 

806,007

 

 

$

24.03

 

 

 

 

 

 

 

Exercised

 

 

(872,520

)

 

$

2.07

 

 

 

 

 

 

 

Forfeited/Expired

 

 

(263,195

)

 

$

4.69

 

 

 

 

 

 

 

Balance at September 30, 2024

 

 

5,203,163

 

 

$

7.52

 

 

 

7.96

 

 

$

157,184

 

Vested and expected to vest at September 30, 2024

 

 

5,203,163

 

 

$

7.52

 

 

 

7.96

 

 

$

157,184

 

Exercisable at September 30, 2024

 

 

1,896,514

 

 

$

3.15

 

 

 

6.51

 

 

$

65,574

 

Summary of Stock-based Compensation Expense Related to Stock Options

Stock-based compensation expense related to stock options and the 2024 Employee Stock Purchase Plan (see Note 9) recorded in the accompanying statements of operations for the three and nine months ended September 30, 2024 and 2023 was as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

$

901

 

 

$

238

 

 

$

2,223

 

 

$

430

 

General and administrative

 

1,748

 

 

 

156

 

 

 

4,189

 

 

 

320

 

Total stock-based compensation expense

$

2,649

 

 

$

394

 

 

$

6,412

 

 

$

750